Related Experiment Video
Updated: Jul 6, 2026
Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Testing COVID-19 in Brazil: fragmented efforts and challenges to expand diagnostic capacity at the Brazilian Unified
Koichi Kameda1,2, Mady Malheiros Barbeitas3, Rosângela Caetano4
1Centre Population et Développement, Paris, France.
Insights
Brazil
Area of Science:
- Public Health
- Epidemiology
- Health Policy
Background:
- Brazil experienced exponential COVID-19 growth post-February 2020.
- National testing strategies proved insufficient for epidemic containment.
- The Brazilian Unified National Health System (SUS) faced significant diagnostic challenges.
Purpose of the Study:
- To investigate factors affecting COVID-19 diagnostic and testing capacity in Brazil.
- To analyze political, industrial, technological, and regulatory aspects impacting testing.
- To evaluate efforts and challenges in scaling up COVID-19 testing within SUS.
Main Methods:
- Review of academic literature and media publications.
- Collection and analysis of public data on test procurement and regulation.
- Examination of initiatives to enhance PCR testing and national technology development.
Main Results:
- Inconsistent national COVID-19 strategy exacerbated supply chain issues for diagnostic components.
- Structural dependency on imported diagnostic materials persists.
- Discontinued funding and distribution led to health policy fragmentation and increased reliance on local actors.
- Post-mid-2020 initiatives expanded SUS testing capacity but were insufficient to control the epidemic.
Conclusions:
- Addressing structural dependencies and ensuring consistent funding are crucial for effective epidemic response.
- Strengthening national diagnostic capabilities is vital for future public health emergencies.
- Enhanced coordination between national, local, and non-state actors is necessary within SUS.
Abstract:
Since the first recorded case of COVID-19 on February 26, 2020, Brazil has seen an exponential growth in the number of cases and deaths. The national testing approach has been insufficient to correctly use this tool in the support of containing the epidemic in the country. In this communication, we discuss efforts and challenges to scale-up COVID-19 testing at the Brazilian Unified National Health System (SUS). This communication presents the initial results of the research project created to investigate the political, industrial, technological, and regulatory aspects that may affect the diagnostic and testing capacity for COVID-19 in Brazil. The paper draws on the review of academic literature, media publication, and collection of public data on tests purchase and regulation. It enlists initiatives to enhance PCR testing, national production and development of technologies, as well as regulatory measures to fast-track new tests. Our analysis indicates some points of reflection. Firstly, the lack of a consistent national strategy to fight COVID-19 exarcebated supply problems of diagnostic components. If the country was eventually able to circumvent this situation, it still faces a more structural dependency on the importation of diagnostic components. Secondly, the discontinued funding and distribution of tests may have implied health policy fragmentation and the growing importance of local governments and non-state actors to fighting the epidemics within SUS. Finally, initiatives established since the second semester of 2020 have expanded the testing capacity at SUS. However, it has not been sufficient to control the progress of the epidemic in the country.
Related Concept Videos
01:18Introduction To Health Care Delivery System
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
01:18Steps in Outbreak Investigation
01:26Principles of Disease Surveillance
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care